In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...